Steven D. Harr

2021 - Sana Biotechnology

In 2021, Steven D. Harr earned a total compensation of $1.2M as President, Chief Executive Officer, and Director at Sana Biotechnology, a 83% decrease compared to previous year.

Compensation breakdown

Bonus$200,000
Non-Equity Incentive Plan$375,000
Salary$611,154
Total$1,186,154

Harr received $611.2K in salary, accounting for 52% of the total pay in 2021.

Harr also received $200K in bonus and $375K in non-equity incentive plan.

Rankings

In 2021, Steven D. Harr's compensation ranked 8,165th out of 12,412 executives tracked by ExecPay. In other words, Harr earned more than 34.2% of executives.

ClassificationRankingPercentile
All
8,165
out of 12,412
34th
Division
Manufacturing
3,610
out of 5,498
34th
Major group
Chemicals And Allied Products
1,606
out of 2,374
32nd
Industry group
Drugs
1,428
out of 2,095
32nd
Industry
Biological Products, Except Diagnostic Substances
319
out of 452
29th
Source: SEC filing on April 26, 2022.

Harr's colleagues

We found two more compensation records of executives who worked with Steven D. Harr at Sana Biotechnology in 2021.

2021

Sunil Agarwal

Sana Biotechnology

Chief Medical Officer

2021

Nathan Hardy

Sana Biotechnology

Chief Financial Officer

News

You may also like